8 results
6-K
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:20am
for all subsequent periods.
SHAREHOLDER ENGAGEMENT
Takeda is committed to regular, ongoing engagement with shareholders to make sure that we continue
6-K
TAK
Takeda Pharmaceutical Co
27 May 20
Current report (foreign)
6:13am
granted in Fiscal Year 2020 and continues to apply for all subsequent periods.
SHAREHOLDER ENGAGEMENT
Takeda is committed to regular, ongoing
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
21 Jun 21
Current report (foreign)
6:05am
and continues to apply for all subsequent periods.
TAKEDA’S EXECUTIVE COMPENSATION OVERVIEW 16 SHAREHOLDER ENGAGEMENT Takeda is committed to regular, ongoing
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
28 May 21
Current report (foreign)
6:07am
to apply for all subsequent periods.
TAKEDA’S EXECUTIVE COMPENSATION OVERVIEW 16 SHAREHOLDER ENGAGEMENT Takeda is committed to regular, ongoing engagement
6-K
TAK
Takeda Pharmaceutical Co
31 May 22
Current report (foreign)
6:18am
to apply for all subsequent periods.
SHAREHOLDER ENGAGEMENT
Takeda is committed to regular, ongoing engagement with shareholders to make sure that we
6-K
qnzb7xw
6 Aug 21
Current report (foreign)
6:10am
6-K
EX-99.1
q3eopjryu
17 Dec 20
Current report (foreign)
6:01am
6-K
EX-99.1
fkzhs
29 Jun 21
Current report (foreign)
7:38am
- Prev
- 1
- Next